Trivarx Ltd has released a press release.
Phase 2 SAMDE Study Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Board and Management Transition
- Letter to Shareholders & Notice of GM & Proxy Form
- Phase 2 Trial Commences for SAMDE Study
- Proposed issue of securities - MEB
- Medibio Receives Firm Commitments to Raise $2.25m
Later from TrivarX
- December 2023 Quarterly Activities Report and Appendix 4C
- TRI-001 Algorithm and Phase 2 Trial Update
- TrivarX Receives $888k R&D Tax Incentive
- Response to ASX Price Query
- Appendix 4D & Half-Year Financial Report to 31 December 2023
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX